Colorectal carcinogenesis:Insights into the cell death and signal transduction pathways:A review
|
摘要
Colorectal carcinogenesis(CRC) imposes a major health burden in developing countries. It is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs are warranted to reduce the severity of this disease. Adenomatous polyps in the colon are the major culprits in CRC and found in 45% of cancers, especially in patients 60 years of age. Inflammatory polyps are currently gaining attention in CRC, and a growing body of evidence denotes the role of inflammation in CRC. Several experimental models are being employed to investigate CRC in animals, which include the APC~(min/+) mouse model, Azoxymethane, Dimethyl hydrazine, and a combination of Dextran sodium sulphate and dimethyl hydrazine. During CRC progression, several signal transduction pathways are activated. Among the major signal transduction pathways are p53, Transforming growth factor beta, Wnt/β-catenin, Delta Notch, Hippo signalling, nuclear factor erythroid 2-related factor 2 and Kelch-like ECH-associated protein 1 pathways. These signalling pathways collaborate with cell death mechanisms, which include apoptosis, necroptosis and autophagy, to determine cell fate. Extensive research has been carried out in our laboratory to investigate these signal transduction and cell death mechanistic pathways in CRC. This review summarizes CRC pathogenesis and the related cell death and signal transduction pathways.
Colorectal carcinogenesis(CRC) imposes a major health burden in developing countries. It is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs are warranted to reduce the severity of this disease. Adenomatous polyps in the colon are the major culprits in CRC and found in 45% of cancers, especially in patients 60 years of age. Inflammatory polyps are currently gaining attention in CRC, and a growing body of evidence denotes the role of inflammation in CRC. Several experimental models are being employed to investigate CRC in animals, which include the APC~(min/+) mouse model, Azoxymethane, Dimethyl hydrazine, and a combination of Dextran sodium sulphate and dimethyl hydrazine. During CRC progression, several signal transduction pathways are activated. Among the major signal transduction pathways are p53, Transforming growth factor beta, Wnt/β-catenin, Delta Notch, Hippo signalling, nuclear factor erythroid 2-related factor 2 and Kelch-like ECH-associated protein 1 pathways. These signalling pathways collaborate with cell death mechanisms, which include apoptosis, necroptosis and autophagy, to determine cell fate. Extensive research has been carried out in our laboratory to investigate these signal transduction and cell death mechanistic pathways in CRC. This review summarizes CRC pathogenesis and the related cell death and signal transduction pathways.
Colorectal carcinogenesis(CRC) imposes a major health burden in developing countries. It is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs are warranted to reduce the severity of this disease. Adenomatous polyps in the colon are the major culprits in CRC and found in 45% of cancers, especially in patients 60 years of age. Inflammatory polyps are currently gaining attention in CRC, and a growing body of evidence denotes the role of inflammation in CRC. Several experimental models are being employed to investigate CRC in animals, which include the APC~(min/+) mouse model, Azoxymethane, Dimethyl hydrazine, and a combination of Dextran sodium sulphate and dimethyl hydrazine. During CRC progression, several signal transduction pathways are activated. Among the major signal transduction pathways are p53, Transforming growth factor beta, Wnt/β-catenin, Delta Notch, Hippo signalling, nuclear factor erythroid 2-related factor 2 and Kelch-like ECH-associated protein 1 pathways. These signalling pathways collaborate with cell death mechanisms, which include apoptosis, necroptosis and autophagy, to determine cell fate. Extensive research has been carried out in our laboratory to investigate these signal transduction and cell death mechanistic pathways in CRC. This review summarizes CRC pathogenesis and the related cell death and signal transduction pathways.
引文
1 Siegel RL,Miller KD,Jemal A.Cancer Statistics,2017.CA Cancer J Clin 2017;67:7-30[PMID:28055103 DOI:10.3322/caac.21387]
2 Gryfe R,Swallow C,Bapat B,Redston M,Gallinger S,Couture J.Molecular biology of colorectal cancer.Curr Probl Cancer 1997;21:233-300[PMID:9438104 DOI:10.1016/S0147-0272(97)80003-7]
3 Tamas K,Walenkamp AM,de Vries EG,van Vugt MA,Beets-Tan RG,van Etten B,de Groot DJ,Hospers GA.Rectal and colon cancer:Not just a different anatomic site.Cancer Treat Rev 2015;41:671-679[PMID:26145760 DOI:10.1016/j.ctrv.2015.06.007]
4 Tariq H,Kamal MU,Mehershahi S,Saad M,Azam S,Kumar K,Niazi M,Makker J,Daniel M.A Rare Case of Colonic Metastases From Tonsillar Carcinoma:Case Report and Review of Literature.World J Oncol 2018;9:35-37[PMID:29581814 DOI:10.14740/wjon1073w]
5 Center MM,Jemal A,Smith RA,Ward E.Worldwide variations in colorectal cancer.CA Cancer J Clin 2009;59:366-378[PMID:19897840 DOI:10.3322/caac.20038]
6 Chatenoud L,Bertuccio P,Bosetti C,Malvezzi M,Levi F,Negri E,La Vecchia C.Trends in mortality from major cancers in the Americas:1980-2010.Ann Oncol 2014;25:1843-1853[PMID:24907637 DOI:10.1093/annonc/mdu206]
7 Deng Y.Rectal Cancer in Asian vs.Western Countries:Why the Variation in Incidence?Curr Treat Options Oncol 2017;18:64[PMID:28948490 DOI:10.1007/s11864-017-0500-2]
8 Pan P,Yu J,Wang LS.Colon Cancer:What We Eat.Surg Oncol Clin N Am 2018;27:243-267[PMID:29496088 DOI:10.1016/j.soc.2017.11.002]
9 Marques-Vidal P,Ravasco P,Ermelinda Camilo M.Foodstuffs and colorectal cancer risk:a review.Clin Nutr 2006;25:14-36[PMID:16290272 DOI:10.1016/j.clnu.2005.09.008]
10 Schwingshackl L,Schwedhelm C,Hoffmann G,Knüppel S,Laure Preterre A,Iqbal K,Bechthold A,De Henauw S,Michels N,Devleesschauwer B,Boeing H,Schlesinger S.Food groups and risk of colorectal cancer.Int J Cancer 2018;142:1748-1758[PMID:29210053 DOI:10.1002/ijc.31198]
11 Calvert PM,Frucht H.The genetics of colorectal cancer.Ann Intern Med 2002;137:603-612[PMID:12353948 DOI:10.7326/0003-4819-137-7-200210010-00012]
12 Williams JG,Pullan RD,Hill J,Horgan PG,Salmo E,Buchanan GN,Rasheed S,Mc Gee SG,Haboubi N;Association of Coloproc-tology of Great Britain and Ireland.Management of the malignant colorectal polyp:ACPGBI position statement.Colorectal Dis 2013;15 Suppl 2:1-38[PMID:23848492 DOI:10.1111/codi.12262]
13 Oving IM,Clevers HC.Molecular causes of colon cancer.Eur JClin Invest 2002;32:448-457[PMID:12059991 DOI:10.1046/j.1365-2362.2002.01004.x]
14 Schoefl R,Ziachehabi A,Wewalka F.Small colorectal polyps.Dig Dis 2015;33:38-41[PMID:25531495 DOI:10.1159/000366034]
15 Angarita FA,Feinberg AE,Feinberg SM,Riddell RH,Mc Cart JA.Management of complex polyps of the colon and rectum.Int JColorectal Dis 2018;33:115-129[PMID:29282496 DOI:10.1007/s00384-017-2950-1]
16 Kim EC,Lance P.Colorectal polyps and their relationship to cancer.Gastroenterol Clin North Am 1997;26:1-17[PMID:9119435 DOI:10.1016/S0889-8553(05)70280-6]
17 Ponz de Leon M,Di Gregorio C.Pathology of colorectal cancer.Dig Liver Dis 2001;33:372-388[PMID:11432519 DOI:10.1016/S1590-8658(01)80095-5]
18 Lord R,Burr NE,Mohammed N,Subramanian V.Colonic lesion characterization in inflammatory bowel disease:A systematic review and meta-analysis.World J Gastroenterol 2018;24:1167-1180[PMID:29563760 DOI:10.3748/wjg.v24.i10.1167]
19 Witold K,Anna K,Maciej T,Jakub J.Adenomas-Genetic factors in colorectal cancer prevention.Rep Pract Oncol Radiother 2018;23:75-83[PMID:29463957 DOI:10.1016/j.rpor.2017.12.003]
20 Boland PM,Yurgelun MB,Boland CR.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.CACancer J Clin 2018;68:217-231[PMID:29485237 DOI:10.3322/caac.21448]
21 Maida M,Macaluso FS,Ianiro G,Mangiola F,Sinagra E,Hold G,Maida C,Cammarota G,Gasbarrini A,Scarpulla G.Screening of colorectal cancer:present and future.Expert Rev Anticancer Ther2017;17:1131-1146[PMID:29022408 DOI:10.1080/14737140.2017.1392243]
22 Yantiss RK,Goodarzi M,Zhou XK,Rennert H,Pirog EC,Banner BF,Chen YT.Clinical,pathologic,and molecular features of early-onset colorectal carcinoma.Am J Surg Pathol 2009;33:572-582[PMID:19047896 DOI:10.1097/PAS.0b013e31818afd6b]
23 Carr PR,Jansen L,Bienert S,Roth W,Herpel E,Kloor M,Bl?ker H,Chang-Claude J,Brenner H,Hoffmeister M.Associations of red and processed meat intake with major molecular pathological features of colorectal cancer.Eur J Epidemiol 2017;32:409-418[PMID:28646407 DOI:10.1007/s10654-017-0275-6]
24 Murff HJ,Shrubsole MJ,Cai Q,Smalley WE,Dai Q,Milne GL,Ness RM,Zheng W.Dietary intake of PUFAs and colorectal polyp risk.Am J Clin Nutr 2012;95:703-712[PMID:22277551 DOI:10.3945/ajcn.111.024000]
25 Kudryavtseva AV,Lipatova AV,Zaretsky AR,Moskalev AA,Fedorova MS,Rasskazova AS,Shibukhova GA,Snezhkina AV,Kaprin AD,Alekseev BY,Dmitriev AA,Krasnov GS.Important molecular genetic markers of colorectal cancer.Oncotarget 2016;7:53959-53983[PMID:27276710 DOI:10.18632/oncotarget.9796]
26 Raskov H,Pommergaard HC,Burcharth J,Rosenberg J.Colorectal carcinogenesis--update and perspectives.World J Gastroenterol2014;20:18151-18164[PMID:25561783 DOI:10.3748/wjg.v20.i48.18151]
27 Burghel GJ,Lin WY,Whitehouse H,Brock I,Hammond D,Bury J,Stephenson Y,George R,Cox A.Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer.PLo S One 2013;8:e83859[PMID:24367615 DOI:10.1371/journal.pone.0083859]
28 Iacopetta B,Grieu F,Amanuel B.Microsatellite instability in colorectal cancer.Asia Pac J Clin Oncol 2010;6:260-269[PMID:21114775 DOI:10.1111/j.1743-7563.2010.01335.x]
29 Slattery ML,Edwards SL,Samowitz W.Stage of colon cancer at diagnosis:implications for risk factor associations?Int J Epidemiol1998;27:382-387[PMID:9698124 DOI:10.1093/ije/27.3.382]
30 Freeman HJ.Early stage colon cancer.World J Gastroenterol 2013;19:8468-8473[PMID:24379564 DOI:10.3748/wjg.v19.i46.8468]
31 Hatano S,Ishida H,Ishibashi K,Kumamoto K,Haga N,Miura I.Identification of risk factors for recurrence in high-risk stage II colon cancer.Int Surg 2013;98:114-121[PMID:23701145 DOI:10.9738/CC131]
32 Robinson JR,Newcomb PA,Hardikar S,Cohen SA,Phipps AI.Stage IV colorectal cancer primary site and patterns of distant metastasis.Cancer Epidemiol 2017;48:92-95[PMID:28437692DOI:10.1016/j.canep.2017.04.003]
33 Johnson RL,Fleet JC.Animal models of colorectal cancer.Cancer Metastasis Rev 2013;32:39-61[PMID:23076650 DOI:10.1007/s10555-012-9404-6]
34 Rosenberg DW,Giardina C,Tanaka T.Mouse models for the study of colon carcinogenesis.Carcinogenesis 2009;30:183-196[PMID:19037092 DOI:10.1093/carcin/bgn267]
35 Edelmann L,Edelmann W.Loss of DNA mismatch repair function and cancer predisposition in the mouse:animal models for human hereditary nonpolyposis colorectal cancer.Am J Med Genet C Semin Med Genet 2004;129C:91-99[PMID:15264277 DOI:10.1002/ajmg.c.30021]
36 Moser AR,Pitot HC,Dove WF.A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.Science1990;247:322-324[PMID:2296722 DOI:10.1007/BF01186825]
37 Heyer J,Yang K,Lipkin M,Edelmann W,Kucherlapati R.Mouse models for colorectal cancer.Oncogene 1999;18:5325-5333[PMID:10498885 DOI:10.1038/sj.onc.1203036]
38 Reichling T,Goss KH,Carson DJ,Holdcraft RW,Ley-Ebert C,Witte D,Aronow BJ,Groden J.Transcriptional profiles of intestinal tumors in Apc(Min)mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.Cancer Res 2005;65:166-176[PMID:15665292]
39 Jin D,Liu T,Dong W,Zhang Y,Wang S,Xie R,Wang B,Cao H.Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apcmin/+mice.Oncotarget 2017;8:97787-97800[PMID:29228651 DOI:10.18632/oncotarget.22081]
40 Huang G,Khan I,Li X,Chen L,Leong W,Ho LT,Hsiao WLW.Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+mice.Sci Rep 2017;7:12552[PMID:28970547 DOI:10.1038/s41598-017-12644-5]
41 Bissahoyo A,Pearsall RS,Hanlon K,Amann V,Hicks D,Godfrey VL,Threadgill DW.Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice:effects of dose,route,and diet.Toxicol Sci 2005;88:340-345[PMID:16150884 DOI:10.1093/toxsci/kfi313]
42 Per?e M,Cerar A.Morphological and molecular alterations in 1,2dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats.J Biomed Biotechnol 2011;2011:473964[PMID:21253581DOI:10.1155/2011/473964]
43 Ashokkumar P,Sudhandiran G.Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway.Invest New Drugs 2011;29:273-284[PMID:20013030 DOI:10.1007/s10637-009-9359-9]
44 Miyaki M,Iijima T,Kimura J,Yasuno M,Mori T,Hayashi Y,Koike M,Shitara N,Iwama T,Kuroki T.Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.Cancer Res 1999;59:4506-4509[PMID:10493496]
45 Umesalma S,Sudhandiran G.Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappa B,i NOS,COX-2,TNF-alpha,and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.Basic Clin Pharmacol Toxicol 2010;107:650-655[PMID:20406206 DOI:10.1111/j.1742-7843.2010.00565.x]
46 Ordás I,Eckmann L,Talamini M,Baumgart DC,Sandborn WJ.Ulcerative colitis.Lancet 2012;380:1606-1619[PMID:22914296DOI:10.1016/S0140-6736(12)60150-0]
47 Kohno H,Suzuki R,Sugie S,Tanaka T.Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.Cancer Sci 2005;96:69-76[PMID:15723650 DOI:10.1111/j.1349-7006.2005.00020.x]
48 Jobst K.Teratogenous changes and tumors in rats following treatment with methylnitroso-urea(MNU).Neoplasma 1967;14:435-436[PMID:6063014]
49 Koestner AW,Ruecker FA,Koestner A.Morphology and pathogenesis of tumors of the thymus and stomach in Sprague-Dawley rats following intragastric administration of methyl nitrosourea(MNU).Int J Cancer 1977;20:418-426[PMID:903192DOI:10.1002/ijc.2910200314]
50 Maekawa A,Onodera H,Kanno J,Furuta K,Nagaoka T,Todate A,Matsushima Y,Oh-hara T,Kawazoe Y.Carcinogenicity and organ specificity of N-trimethylsilylmethyl-N-nitrosourea(TMS-MNU),N-neopentyl-N-nitrosourea(neo PNU),and N-methyl-N-nitrosourea(MNU)in rats.J Cancer Res Clin Oncol 1988;114:473-476[PMID:3182906 DOI:10.1007/BF00391494]
51 Almora-Pinedo Y,Arroyo-Acevedo J,Herrera-Calderon O,Chumpitaz-Cerrate V,Ha?ari-Quispe R,Tinco-Jayo A,Franco-Quino C,Figueroa-Salvador L.Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU)induced gastric cancer in rats.Clin Exp Gastroenterol 2017;10:327-332[PMID:29270029 DOI:10.2147/CEG.S142515]
52 Pollard M,Luckert PH.Autochthonous prostate adenocarcinomas in Lobund-Wistar rats:a model system.Prostate 1987;11:219-227[PMID:3684782 DOI:10.1002/pros.2990110303]
53 Narisawa T,Wong CQ,Maronpot RR,Weisburger JH.Large bowel carcinogenesis in mice and rats by several intrarectal doses of methylnitrosourea and negative effect of nitrite plus methylurea.Cancer Res 1976;36:505-510[PMID:1260748]
54 Magalh?es B,Peleteiro B,Lunet N.Dietary patterns and colorectal cancer:systematic review and meta-analysis.Eur JCancer Prev 2012;21:15-23[PMID:21946864 DOI:10.1097/CEJ.0b013e3283472241]
55 Newmark HL,Yang K,Kurihara N,Fan K,Augenlicht LH,Lipkin M.Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice:a preclinical model for human sporadic colon cancer.Carcinogenesis 2009;30:88-92[PMID:19017685 DOI:10.1093/carcin/bgn229]
56 Newmark HL,Lipkin M,Maheshwari N.Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet.J Natl Cancer Inst 1990;82:491-496[PMID:2313721 DOI:10.1093/jnci/82.6.491]
57 Risio M,Lipkin M,Newmark H,Yang K,Rossini FP,Steele VE,Boone CW,Kelloff GJ.Apoptosis,cell replication,and Western-style diet-induced tumorigenesis in mouse colon.Cancer Res 1996;56:4910-4916[PMID:8895743]
58 Wang D,Peregrina K,Dhima E,Lin EY,Mariadason JM,Augenlicht LH.Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer.Proc Natl Acad Sci USA 2011;108:10272-10277[PMID:21652773 DOI:10.1073/pnas.1017668108]
59 Muto T,Bussey HJ,Morson BC.The evolution of cancer of the colon and rectum.Cancer 1975;36:2251-2270[PMID:1203876DOI:10.1002/cncr.2820360944]
60 Subramaniam R,Mizoguchi A,Mizoguchi E.Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.Cancer Res Front 2016;2:1-21[PMID:27110580 DOI:10.17980/2016.1]
61 Xu J,Lamouille S,Derynck R.TGF-beta-induced epithelial to mesenchymal transition.Cell Res 2009;19:156-172[PMID:19153598 DOI:10.1038/cr.2009.5]
62 Varga J,Greten FR.Cell plasticity in epithelial homeostasis and tumorigenesis.Nat Cell Biol 2017;19:1133-1141[PMID:28945230DOI:10.1038/ncb3611]
63 Thiery JP,Acloque H,Huang RY,Nieto MA.Epithelial-mes-enchymal transitions in development and disease.Cell 2009;139:871-890[PMID:19945376 DOI:10.1016/j.cell.2009.11.007]
64?kovierováH,Okaj?ekováT,Strnádel J,VidomanováE,Hala?ováE.Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis(Review).Int J Mol Med 2018;41:1187-1200[PMID:29286071 DOI:10.3892/ijmm.2017.3320]
65 Ansieau S,Bastid J,Doreau A,Morel AP,Bouchet BP,Thomas C,Fauvet F,Puisieux I,Doglioni C,Piccinin S,Maestro R,Voeltzel T,Selmi A,Valsesia-Wittmann S,Caron de Fromentel C,Puisieux A.Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.Cancer Cell 2008;14:79-89[PMID:18598946 DOI:10.1016/j.ccr.2008.06.005]
66 Lazarova DL,Bordonaro M.Vimentin,colon cancer progression and resistance to butyrate and other HDACis.J Cell Mol Med 2016;20:989-993[PMID:27072512 DOI:10.1111/jcmm.12850]
67 Meacham CE,Morrison SJ.Tumour heterogeneity and cancer cell plasticity.Nature 2013;501:328-337[PMID:24048065 DOI:10.1038/nature12624]
68 Yao D,Dai C,Peng S.Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.Mol Cancer Res 2011;9:1608-1620[PMID:21840933 DOI:10.1158/1541-7786.MCR-10-0568]
69 Christou N,Perraud A,Blondy S,Jauberteau MO,Battu S,Mathonnet M.E-cadherin:A potential biomarker of colorectal cancer prognosis.Oncol Lett 2017;13:4571-4576[PMID:28588719 DOI:10.3892/ol.2017.6063]
70 Choi BJ,Park SA,Lee SY,Cha YN,Surh YJ.Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail:Apotential role of Sox9.Sci Rep 2017;7:15918[PMID:29162839DOI:10.1038/s41598-017-15139-5]
71 Loboda A,Nebozhyn MV,Watters JW,Buser CA,Shaw PM,Huang PS,Van't Veer L,Tollenaar RA,Jackson DB,Agrawal D,Dai H,Yeatman TJ.EMT is the dominant program in human colon cancer.BMC Med Genomics 2011;4:9[PMID:21251323 DOI:10.1186/1755-8794-4-9]
72 Clarke PG,Clarke S.Nineteenth century research on naturally occurring cell death and related phenomena.Anat Embryol(Berl)1996;193:81-99[PMID:8742050 DOI:10.1007/BF00214700]
73 Galluzzi L,Vitale I,Aaronson SA,Abrams JM,Adam D,Agostinis P,Alnemri ES,Altucci L,Amelio I,Andrews DW,Annicchiarico-Petruzzelli M,Antonov AV,Arama E,Baehrecke EH,Barlev NA,Bazan NG,Bernassola F,Bertrand MJM,Bianchi K,Blagosklonny MV,Blomgren K,Borner C,Boya P,Brenner C,Campanella M,Candi E,Carmona-Gutierrez D,Cecconi F,Chan FK,Chandel NS,Cheng EH,Chipuk JE,Cidlowski JA,Ciechanover A,Cohen GM,Conrad M,Cubillos-Ruiz JR,Czabotar PE,D'Angiolella V,Dawson TM,Dawson VL,De Laurenzi V,De Maria R,Debatin KM,De Berardinis RJ,Deshmukh M,Di Daniele N,Di Virgilio F,Dixit VM,Dixon SJ,Duckett CS,Dynlacht BD,El-Deiry WS,Elrod JW,Fimia GM,Fulda S,García-Sáez AJ,Garg AD,Garrido C,Gavathiotis E,Golstein P,Gottlieb E,Green DR,Greene LA,Gronemeyer H,Gross A,Hajnoczky G,Hardwick JM,Harris IS,Hengartner MO,Hetz C,Ichijo H,J??ttel?M,Joseph B,Jost PJ,Juin PP,Kaiser WJ,Karin M,Kaufmann T,Kepp O,Kimchi A,Kitsis RN,Klionsky DJ,Knight RA,Kumar S,Lee SW,Lemasters JJ,Levine B,Linkermann A,Lipton SA,Lockshin RA,López-Otín C,Lowe SW,Luedde T,Lugli E,Mac Farlane M,Madeo F,Malewicz M,Malorni W,Manic G,Marine JC,Martin SJ,Martinou JC,Medema JP,Mehlen P,Meier P,Melino S,Miao EA,Molkentin JD,Moll UM,Mu?oz-Pinedo C,Nagata S,Nu?ez G,Oberst A,Oren M,Overholtzer M,Pagano M,Panaretakis T,Pasparakis M,Penninger JM,Pereira DM,Pervaiz S,Peter ME,Piacentini M,Pinton P,Prehn JHM,Puthalakath H,Rabinovich GA,Rehm M,Rizzuto R,Rodrigues CMP,Rubinsztein DC,Rudel T,Ryan KM,Sayan E,Scorrano L,Shao F,Shi Y,Silke J,Simon HU,Sistigu A,Stockwell BR,Strasser A,Szabadkai G,Tait SWG,Tang D,Tavernarakis N,Thorburn A,Tsujimoto Y,Turk B,Vanden Berghe T,Vandenabeele P,Vander Heiden MG,Villunger A,Virgin HW,Vousden KH,Vucic D,Wagner EF,Walczak H,Wallach D,Wang Y,Wells JA,Wood W,Yuan J,Zakeri Z,Zhivotovsky B,Zitvogel L,Melino G,Kroemer G.Molecular mechanisms of cell death:recommendations of the Nomenclature Committee on Cell Death2018.Cell Death Differ 2018;25:486-541[PMID:29362479 DOI:10.1038/s41418-017-0012-4]
74 Fulda S.Regulation of cell death in cancer-possible implications for immunotherapy.Front Oncol 2013;3:29[PMID:23441073 DOI:10.3389/fonc.2013.00029]
75 Letai A.Cell Death and Cancer Therapy:Don't Forget to Kill the Cancer Cell!Clin Cancer Res 2015;21:5015-5020[PMID:26567360 DOI:10.1158/1078-0432.CCR-15-1204]
76 Ricci MS,Zong WX.Chemotherapeutic approaches for targeting cell death pathways.Oncologist 2006;11:342-357[PMID:16614230 DOI:10.1634/theoncologist.11-4-342]
77 Nievelstein RA,van der Werff JF,Verbeek FJ,Valk J,Vermeij-Keers C.Normal and abnormal embryonic development of the anorectum in human embryos.Teratology 1998;57:70-78[PMID:9562679 DOI:10.1002/(SICI)1096-9926(199802)57:2<70::AID-TERA5>3.0.CO;2-A]
78 Zhang T,Zhang HL,Wang da J,Tang XB,Jia HM,Bai YZ,Yuan ZW,Wang WL.Normal development of hindgut and anorectum in human embryo.Int J Colorectal Dis 2011;26:109-116[PMID:20686776 DOI:10.1007/s00384-010-1034-2]
79 Nakata M,Takada Y,Hishiki T,Saito T,Terui K,Sato Y,Koseki H,Yoshida H.Induction of Wnt5a-expressing mesenchymal cells adjacent to the cloacal plate is an essential process for its proximodistal elongation and subsequent anorectal development.Pediatr Res 2009;66:149-154[PMID:19390486 DOI:10.1203/PDR.0b013e3181aa304a]
80 Zhang T,Tang XB,Wang LL,Bai YZ,Qiu GR,Yuan ZW,Wang WL.Mutations and down-regulation of CDX1 in children with anorectal malformations.Int J Med Sci 2013;10:191-197[PMID:23329892 DOI:10.7150/ijms.4929]
81 Qu X,Zou Z,Sun Q,Luby-Phelps K,Cheng P,Hogan RN,Gilpin C,Levine B.Autophagy gene-dependent clearance of apoptotic cells during embryonic development.Cell 2007;128:931-946[PMID:17350577 DOI:10.1016/j.cell.2006.12.044]
82 Yuan J,Kroemer G.Alternative cell death mechanisms in development and beyond.Genes Dev 2010;24:2592-2602[PMID:21123646 DOI:10.1101/gad.1984410]
83 Zhou W,Yuan J.Necroptosis in health and diseases.Semin Cell Dev Biol 2014;35:14-23[PMID:25087983 DOI:10.1016/j.semcdb.2014.07.013]
84 Xie Y,Hou W,Song X,Yu Y,Huang J,Sun X,Kang R,Tang D.Ferroptosis:process and function.Cell Death Differ 2016;23:369-379[PMID:26794443 DOI:10.1038/cdd.2015.158]
85 Vande Walle L,Lamkanfi M.Pyroptosis.Curr Biol 2016;26:R568-R572[PMID:27404251 DOI:10.1016/j.cub.2016.02.019]
86 Fatokun AA,Dawson VL,Dawson TM.Parthanatos:mitochondrial-linked mechanisms and therapeutic opportunities.Br J Pharmacol2014;171:2000-2016[PMID:24684389 DOI:10.1111/bph.12416]
87 Kroemer G,Perfettini JL.Entosis,a key player in cancer cell competition.Cell Res 2014;24:1280-1281[PMID:25342563 DOI:10.1038/cr.2014.133]
88 Mesa MA,Vasquez G.NETosis.Autoimmune Dis 2013;2013:651497[PMID:23476749 DOI:10.1155/2013/651497]
89 Kim KH,Lee MS.Autophagy--a key player in cellular and body metabolism.Nat Rev Endocrinol 2014;10:322-337[PMID:24663220 DOI:10.1038/nrendo.2014.35]
90 Galluzzi L,Bravo-San Pedro JM,Kepp O,Kroemer G.Regulated cell death and adaptive stress responses.Cell Mol Life Sci 2016;73:2405-2410[PMID:27048813 DOI:10.1007/s00018-016-2209-y]
91 Wong DJ,Liu H,Ridky TW,Cassarino D,Segal E,Chang HY.Module map of stem cell genes guides creation of epithelial cancer stem cells.Cell Stem Cell 2008;2:333-344[PMID:18397753 DOI:10.1016/j.stem.2008.02.009]
92 Fearon ER.Molecular genetics of colorectal cancer.Annu Rev Pathol 2011;6:479-507[PMID:21090969 DOI:10.1146/annurev-pathol-011110-130235]
93 Marshman E,Ottewell PD,Potten CS,Watson AJ.Caspase acti-vation during spontaneous and radiation-induced apoptosis in the murine intestine.J Pathol 2001;195:285-292[PMID:11673824DOI:10.1002/path.967]
94 Manne U,Shanmugam C,Katkoori VR,Bumpers HL,Grizzle WE.Development and progression of colorectal neoplasia.Cancer Biomark 2010;9:235-265[PMID:22112479 DOI:10.3233/CBM-2011-0160]
95 Li XL,Zhou J,Chen ZR,Chng WJ.P53 mutations in colorectal cancer-molecular pathogenesis and pharmacological reactivation.World J Gastroenterol 2015;21:84-93[PMID:25574081 DOI:10.3748/wjg.v21.i1.84]
96 Kumar M,Kaur V,Kumar S,Kaur S.Phytoconstituents as apoptosis inducing agents:strategy to combat cancer.Cytotechnology 2016;68:531-563[PMID:26239338 DOI:10.1007/s10616-015-9897-2]
97 Pandurangan AK,Dharmalingam P,Sadagopan SK,Ramar M,Munusamy A,Ganapasam S.Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/GSK-3βsignaling.J Environ Pathol Toxicol Oncol 2013;32:131-139[PMID:24099426 DOI:10.1615/JEnviron Pathol Toxicol Oncol.2013007522]
98 Gerola S,Nittka S,K?hler G,Tao S,Brenner H,Binelli G,Eils R,Brors B,Neumaier M.Genetic variants in apoptosis-related genes associated with colorectal hyperplasia.Genes Chromosomes Cancer2014;53:769-778[PMID:24861865 DOI:10.1002/gcc.22185]
99 Sinicrope FA,Hart J,Hsu HA,Lemoine M,Michelassi F,Stephens LC.Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.Clin Cancer Res 1999;5:1793-1804[PMID:10430084]
100 Danielsen SA,Eide PW,Nesbakken A,Guren T,Leithe E,Lothe RA.Portrait of the PI3K/AKT pathway in colorectal cancer.Biochim Biophys Acta 2015;1855:104-121[PMID:25450577 DOI:10.1016/j.bbcan.2014.09.008]
101 Kenific CM,Thorburn A,Debnath J.Autophagy and metastasis:another double-edged sword.Curr Opin Cell Biol 2010;22:241-245[PMID:19945838 DOI:10.1016/j.ceb.2009.10.008]
102 Chen Z,Li Y,Zhang C,Yi H,Wu C,Wang J,Liu Y,Tan J,Wen J.Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer.Dig Dis Sci 2013;58:2887-2894[PMID:23812859 DOI:10.1007/s10620-013-2732-8]
103 Moriwaki K,Bertin J,Gough PJ,Orlowski GM,Chan FK.Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Cell Death Dis2015;6:e1636[PMID:25675296 DOI:10.1038/cddis.2015.16]
104 Xie X,Zhao Y,Ma CY,Xu XM,Zhang YQ,Wang CG,Jin J,Shen X,Gao JL,Li N,Sun ZJ,Dong DL.Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROSincrease/MAPKs activation pathway.Br J Pharmacol 2015;172:3929-3943[PMID:25953698 DOI:10.1111/bph.13184]
105 Oliver Metzig M,Fuchs D,Tagscherer KE,Gr?ne HJ,Schirmacher P,Roth W.Inhibition of caspases primes colon cancer cells for5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.Oncogene 2016;35:3399-3409[PMID:26522725 DOI:10.1038/onc.2015.398]
106 Katz LH,Li Y,Chen JS,Mu?oz NM,Majumdar A,Chen J,Mishra L.Targeting TGF-βsignaling in cancer.Expert Opin Ther Targets2013;17:743-760[PMID:23651053 DOI:10.1517/14728222.2013.782287]
107 Goel S,Huang J,Klampfer L.K-Ras,intestinal homeostasis and colon cancer.Curr Clin Pharmacol 2015;10:73-81[PMID:24219000 DOI:10.2174/1574884708666131111204440]
108 Giles RH,van Es JH,Clevers H.Caught up in a Wnt storm:Wnt signaling in cancer.Biochim Biophys Acta 2003;1653:1-24[PMID:12781368 DOI:10.1016/S0304-419X(03)00005-2]
109 Segditsas S,Tomlinson I.Colorectal cancer and genetic alterations in the Wnt pathway.Oncogene 2006;25:7531-7537[PMID:17143297 DOI:10.1038/sj.onc.1210059]
110 Rosin-Arbesfeld R,Townsley F,Bienz M.The APC tumour suppressor has a nuclear export function.Nature 2000;406:1009-1012[PMID:10984057 DOI:10.1038/35023016]
111 Fevr T,Robine S,Louvard D,Huelsken J.Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.Mol Cell Biol 2007;27:7551-7559[PMID:17785439DOI:10.1128/MCB.01034-07]
112 Hanahan D,Weinberg RA.Hallmarks of cancer:the next genera-tion.Cell 2011;144:646-674[PMID:21376230 DOI:10.1016/j.cell.2011.02.013]
113 Fortin J,Mak TW.Targeting PI3K Signaling in Cancer:ACautionary Tale of Two AKTs.Cancer Cell 2016;29:429-431[PMID:27070694 DOI:10.1016/j.ccell.2016.03.020]
114 Colakoglu T,Yildirim S,Kayaselcuk F,Nursal TZ,Ezer A,Noyan T,Karakayali H,Haberal M.Clinicopathological significance of PTENloss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms:is PTEN loss predictor of local recurrence?Am J Surg 2008;195:719-725[PMID:18440486 DOI:10.1016/j.amjsurg.2007.05.061]
115 Lin MC,Wang FY,Kuo YH,Tang FY.Cancer chemopreventive effects of lycopene:suppression of MMP-7 expression and cell invasion in human colon cancer cells.J Agric Food Chem 2011;59:11304-11318[PMID:21923160 DOI:10.1021/jf202433f]
116 Din FV,Valanciute A,Houde VP,Zibrova D,Green KA,Sakamoto K,Alessi DR,Dunlop MG.Aspirin inhibits m TOR signaling,activates AMP-activated protein kinase,and induces autophagy in colorectal cancer cells.Gastroenterology 2012;142:1504-1515.e3[PMID:22406476 DOI:10.1053/j.gastro.2012.02.050]
117 MassaguéJ.TGF-beta signal transduction.Annu Rev Biochem1998;67:753-791[PMID:9759503 DOI:10.1146/annurev.biochem.67.1.753]
118 Kaklamani VG,Pasche B.Role of TGF-beta in cancer and the potential for therapy and prevention.Expert Rev Anticancer Ther2004;4:649-661[PMID:15270668 DOI:10.1586/14737140.4.4.649]
119 Xu Y,Pasche B.TGF-beta signaling alterations and susceptibility to colorectal cancer.Hum Mol Genet 2007;16 Spec No 1:R14-R20[PMID:17613544 DOI:10.1093/hmg/ddl486]
120 Leask A,Abraham DJ.TGF-beta signaling and the fibrotic response.FASEB J 2004;18:816-827[PMID:15117886 DOI:10.1096/fj.03-1273rev]
121 Javelaud D,Mauviel A.Mammalian transforming growth factor-betas:Smad signaling and physio-pathological roles.Int J Biochem Cell Biol 2004;36:1161-1165[PMID:15109563 DOI:10.1016/S1357-2725(03)00255-3]
122 Clark DA,Coker R.Transforming growth factor-beta(TGF-beta).Int J Biochem Cell Biol 1998;30:293-298[PMID:9611771 DOI:10.1016/S1357-2725(97)00128-3]
123 Bellam N,Pasche B.Tgf-beta signaling alterations and colon cancer.Cancer Treat Res 2010;155:85-103[PMID:20517689 DOI:10.1007/978-1-4419-6033-7_5]
124 Letterio JJ,Roberts AB.Regulation of immune responses by TGF-beta.Annu Rev Immunol 1998;16:137-161[PMID:9597127 DOI:10.1146/annurev.immunol.16.1.137]
125 Geng L,Chaudhuri A,Talmon G,Wisecarver JL,Wang J.TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.PLo S One 2013;8:e59918[PMID:23536895 DOI:10.1371/journal.pone.0059918]
126 Gatza CE,Holtzhausen A,Kirkbride KC,Morton A,Gatza ML,Datto MB,Blobe GC.Type III TGF-βreceptor enhances colon cancer cell migration and anchorage-independent growth.Neoplasia2011;13:758-770[PMID:21847367 DOI:10.1593/neo.11528]
127 Oshima H,Nakayama M,Han TS,Naoi K,Ju X,Maeda Y,Robine S,Tsuchiya K,Sato T,Sato H,Taketo MM,Oshima M.Suppressing TGFβsignaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.Cancer Res 2015;75:766-776[PMID:25687406 DOI:10.1158/0008-5472.CAN-14-2036]
128 Ruzzo A,Graziano F,Canestrari E,Magnani M.Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.Curr Cancer Drug Targets 2010;10:68-79[PMID:20088793 DOI:10.2174/156800910790980205]
129 Mendelsohn J.The epidermal growth factor receptor as a target for cancer therapy.Endocr Relat Cancer 2001;8:3-9[PMID:11350723DOI:10.1677/erc.0.0080003]
130 Rotter V,Prokocimer M.p53 and human malignancies.Adv Cancer Res 1991;57:257-272[PMID:1950705 DOI:10.1016/S0065-230X(08)61001-5]
131 Hsieh JS,Lin SR,Chang MY,Chen FM,Lu CY,Huang TJ,Huang YS,Huang CJ,Wang JY.APC,K-ras,and p53 gene mutations in colorectal cancer patients:correlation to clinicopathologic features and postoperative surveillance.Am Surg 2005;71:336-343[PMID:15943410]
132 Artavanis-Tsakonas S,Rand MD,Lake RJ.Notch signaling:cell fate control and signal integration in development.Science 1999;284:770-776[PMID:10221902 DOI:10.1126/science.284.5415.770]
133 Bray SJ.Notch signalling in context.Nat Rev Mol Cell Biol 2016;17:722-735[PMID:27507209 DOI:10.1038/nrm.2016.94]
134 Schmidt EM,Lamprecht S,Blaj C,Schaaf C,Krebs S,Blum H,Hermeking H,Jung A,Kirchner T,Horst D.Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer.J Exp Med 2018;215:1693-1708[PMID:29769248DOI:10.1084/jem.20171455]
135 Mirone G,Perna S,Shukla A,Marfe G.Involvement of Notch-1in Resistance to Regorafenib in Colon Cancer Cells.J Cell Physiol2016;231:1097-1105[PMID:26419617 DOI:10.1002/jcp.25206]
136 Kranenburg O.Prometastatic NOTCH Signaling in Colon Cancer.Cancer Discov 2015;5:115-117[PMID:25656897 DOI:10.1158/2159-8290.CD-14-1456]
137 Rajendran P,Dashwood WM,Li L,Kang Y,Kim E,Johnson G,Fischer KA,L?hr CV,Williams DE,Ho E,Yamamoto M,Lieberman DA,Dashwood RH.Nrf2 status affects tumor growth,HDAC3 gene promoter associations,and the response to sulforaphane in the colon.Clin Epigenetics 2015;7:102[PMID:26388957 DOI:10.1186/s13148-015-0132-y]
138 Copple IM.The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?Adv Pharmacol 2012;63:43-79[PMID:22776639 DOI:10.1016/B978-0-12-398339-8.00002-1]
139 Manigandan K,Manimaran D,Jayaraj RL,Elangovan N,Dhivya V,Kaphle A.Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.Biochimie 2015;119:103-112[PMID:26482805DOI:10.1016/j.biochi.2015.10.014]
140 Niture SK,Khatri R,Jaiswal AK.Regulation of Nrf2-an update.Free Radic Biol Med 2014;66:36-44[PMID:23434765 DOI:10.1016/j.freeradbiomed.2013.02.008]
141 Jaramillo MC,Zhang DD.The emerging role of the Nrf2-Keap1signaling pathway in cancer.Genes Dev 2013;27:2179-2191[PMID:24142871 DOI:10.1101/gad.225680.113]
142 Yang Y,Cai X,Yang J,Sun X,Hu C,Yan Z,Xu X,Lu W,Wang X,Cao P.Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation.Mol Cancer 2014;13:48[PMID:24602443 DOI:10.1186/1476-4598-13-48]
143 Yao J,Zhao L,Zhao Q,Zhao Y,Sun Y,Zhang Y,Miao H,You QD,Hu R,Guo QL.NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis.Cell Death Dis 2014;5:e1283[PMID:24901054DOI:10.1038/cddis.2014.221]
144 Wondrak GT,Villeneuve NF,Lamore SD,Bause AS,Jiang T,Zhang DD.The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells.Molecules 2010;15:3338-3355[PMID:20657484 DOI:10.3390/molecules15053338]
145 Irvine KD,Harvey KF.Control of organ growth by patterning and hippo signaling in Drosophila.Cold Spring Harb Perspect Biol2015;7:pii:a019224[PMID:26032720 DOI:10.1101/cshperspect.a019224]
146 Kosik KS,Kowall NW,Mc Kee A.Along the way to a neurofibrillary tangle:a look at the structure of tau.Ann Med 1989;21:109-112[PMID:2504256 DOI:10.3109/07853898909149195]
147 Santucci M,Vignudelli T,Ferrari S,Mor M,Scalvini L,Bolognesi ML,Uliassi E,Costi MP.The Hippo Pathway and YAP/TAZ-TEADProtein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.J Med Chem 2015;58:4857-4873[PMID:25719868 DOI:10.1021/jm501615v]
148 Nagashima S,Bao Y,Hata Y.The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.Curr Drug Targets2017;18:447-454[PMID:26758663 DOI:10.2174/1389450117666160112115641]
149 Guo L,Teng L.YAP/TAZ for cancer therapy:opportunities and challenges(review).Int J Oncol 2015;46:1444-1452[PMID:25652178 DOI:10.3892/ijo.2015.2877]
150 Hansen CG,Moroishi T,Guan KL.YAP and TAZ:a nexus for Hippo signaling and beyond.Trends Cell Biol 2015;25:499-513[PMID:26045258 DOI:10.1016/j.tcb.2015.05.002]
151 Liang K,Zhou G,Zhang Q,Li J,Zhang C.Expression of hippo pathway in colorectal cancer.Saudi J Gastroenterol 2014;20:188-194[PMID:24976283 DOI:10.4103/1319-3767.133025]
152 Cho SY,Gwak JW,Shin YC,Moon D,Ahn J,Sol HW,Kim S,Kim G,Shin HM,Lee KH,Kim JY,Kim JS.Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.Oncol Lett 2018;15:4926-4936[PMID:29541248DOI:10.3892/ol.2018.7911]
153 Konsavage WM Jr,Kyler SL,Rennoll SA,Jin G,Yochum GS.Wnt/β-catenin signaling regulates Yes-associated protein(YAP)gene expression in colorectal carcinoma cells.J Biol Chem 2012;287:11730-11739[PMID:22337891 DOI:10.1074/jbc.M111.327767]
154 Kim M,Jho EH.Cross-talk between Wnt/β-catenin and Hippo signaling pathways:a brief review.BMB Rep 2014;47:540-545[PMID:25154721 DOI:10.5483/BMBRep.2014.47.10.177]
155 Tanaka T.Colorectal carcinogenesis:Review of human and experimental animal studies.J Carcinog 2009;8:5[PMID:19332896 DOI:10.4103/1477-3163.49014]
156 Rupaimoole R,Slack FJ.Micro RNA therapeutics:towards a new era for the management of cancer and other diseases.Nat Rev Drug Discov 2017;16:203-222[PMID:28209991 DOI:10.1038/nrd.2016.246]
157 Jansson MD,Lund AH.Micro RNA and cancer.Mol Oncol 2012;6:590-610[PMID:23102669 DOI:10.1016/j.molonc.2012.09.006]
158 Masuda T,Hayashi N,Kuroda Y,Ito S,Eguchi H,Mimori K.Micro RNAs as Biomarkers in Colorectal Cancer.Cancers(Basel)2017;9:pii:E124[PMID:28902152 DOI:10.3390/cancers9090124]
159 DegagnéE,Pandurangan A,Bandhuvula P,Kumar A,Eltanawy A,Zhang M,Yoshinaga Y,Nefedov M,de Jong PJ,Fong LG,Young SG,Bittman R,Ahmedi Y,Saba JD.Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated micro RNAs.J Clin Invest 2014;124:5368-5384[PMID:25347472 DOI:10.1172/JCI74188]
160 Cao L,Liu Y,Wang D,Huang L,Li F,Liu J,Zhang C,Shen Z,Gao Q,Yuan W,Zhang Y.Mi R-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclin D1 signaling.J Exp Clin Cancer Res 2018;37:83[PMID:29661228 DOI:10.1186/s13046-018-0757-8]
161 Zhang W,Sun Z,Su L,Wang F,Jiang Y,Yu D,Zhang F,Sun Z,Liang W.mi RNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.Eur JPharmacol 2018;825:75-84[PMID:29454608 DOI:10.1016/j.ejphar.2018.02.019]
2 Gryfe R,Swallow C,Bapat B,Redston M,Gallinger S,Couture J.Molecular biology of colorectal cancer.Curr Probl Cancer 1997;21:233-300[PMID:9438104 DOI:10.1016/S0147-0272(97)80003-7]
3 Tamas K,Walenkamp AM,de Vries EG,van Vugt MA,Beets-Tan RG,van Etten B,de Groot DJ,Hospers GA.Rectal and colon cancer:Not just a different anatomic site.Cancer Treat Rev 2015;41:671-679[PMID:26145760 DOI:10.1016/j.ctrv.2015.06.007]
4 Tariq H,Kamal MU,Mehershahi S,Saad M,Azam S,Kumar K,Niazi M,Makker J,Daniel M.A Rare Case of Colonic Metastases From Tonsillar Carcinoma:Case Report and Review of Literature.World J Oncol 2018;9:35-37[PMID:29581814 DOI:10.14740/wjon1073w]
5 Center MM,Jemal A,Smith RA,Ward E.Worldwide variations in colorectal cancer.CA Cancer J Clin 2009;59:366-378[PMID:19897840 DOI:10.3322/caac.20038]
6 Chatenoud L,Bertuccio P,Bosetti C,Malvezzi M,Levi F,Negri E,La Vecchia C.Trends in mortality from major cancers in the Americas:1980-2010.Ann Oncol 2014;25:1843-1853[PMID:24907637 DOI:10.1093/annonc/mdu206]
7 Deng Y.Rectal Cancer in Asian vs.Western Countries:Why the Variation in Incidence?Curr Treat Options Oncol 2017;18:64[PMID:28948490 DOI:10.1007/s11864-017-0500-2]
8 Pan P,Yu J,Wang LS.Colon Cancer:What We Eat.Surg Oncol Clin N Am 2018;27:243-267[PMID:29496088 DOI:10.1016/j.soc.2017.11.002]
9 Marques-Vidal P,Ravasco P,Ermelinda Camilo M.Foodstuffs and colorectal cancer risk:a review.Clin Nutr 2006;25:14-36[PMID:16290272 DOI:10.1016/j.clnu.2005.09.008]
10 Schwingshackl L,Schwedhelm C,Hoffmann G,Knüppel S,Laure Preterre A,Iqbal K,Bechthold A,De Henauw S,Michels N,Devleesschauwer B,Boeing H,Schlesinger S.Food groups and risk of colorectal cancer.Int J Cancer 2018;142:1748-1758[PMID:29210053 DOI:10.1002/ijc.31198]
11 Calvert PM,Frucht H.The genetics of colorectal cancer.Ann Intern Med 2002;137:603-612[PMID:12353948 DOI:10.7326/0003-4819-137-7-200210010-00012]
12 Williams JG,Pullan RD,Hill J,Horgan PG,Salmo E,Buchanan GN,Rasheed S,Mc Gee SG,Haboubi N;Association of Coloproc-tology of Great Britain and Ireland.Management of the malignant colorectal polyp:ACPGBI position statement.Colorectal Dis 2013;15 Suppl 2:1-38[PMID:23848492 DOI:10.1111/codi.12262]
13 Oving IM,Clevers HC.Molecular causes of colon cancer.Eur JClin Invest 2002;32:448-457[PMID:12059991 DOI:10.1046/j.1365-2362.2002.01004.x]
14 Schoefl R,Ziachehabi A,Wewalka F.Small colorectal polyps.Dig Dis 2015;33:38-41[PMID:25531495 DOI:10.1159/000366034]
15 Angarita FA,Feinberg AE,Feinberg SM,Riddell RH,Mc Cart JA.Management of complex polyps of the colon and rectum.Int JColorectal Dis 2018;33:115-129[PMID:29282496 DOI:10.1007/s00384-017-2950-1]
16 Kim EC,Lance P.Colorectal polyps and their relationship to cancer.Gastroenterol Clin North Am 1997;26:1-17[PMID:9119435 DOI:10.1016/S0889-8553(05)70280-6]
17 Ponz de Leon M,Di Gregorio C.Pathology of colorectal cancer.Dig Liver Dis 2001;33:372-388[PMID:11432519 DOI:10.1016/S1590-8658(01)80095-5]
18 Lord R,Burr NE,Mohammed N,Subramanian V.Colonic lesion characterization in inflammatory bowel disease:A systematic review and meta-analysis.World J Gastroenterol 2018;24:1167-1180[PMID:29563760 DOI:10.3748/wjg.v24.i10.1167]
19 Witold K,Anna K,Maciej T,Jakub J.Adenomas-Genetic factors in colorectal cancer prevention.Rep Pract Oncol Radiother 2018;23:75-83[PMID:29463957 DOI:10.1016/j.rpor.2017.12.003]
20 Boland PM,Yurgelun MB,Boland CR.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.CACancer J Clin 2018;68:217-231[PMID:29485237 DOI:10.3322/caac.21448]
21 Maida M,Macaluso FS,Ianiro G,Mangiola F,Sinagra E,Hold G,Maida C,Cammarota G,Gasbarrini A,Scarpulla G.Screening of colorectal cancer:present and future.Expert Rev Anticancer Ther2017;17:1131-1146[PMID:29022408 DOI:10.1080/14737140.2017.1392243]
22 Yantiss RK,Goodarzi M,Zhou XK,Rennert H,Pirog EC,Banner BF,Chen YT.Clinical,pathologic,and molecular features of early-onset colorectal carcinoma.Am J Surg Pathol 2009;33:572-582[PMID:19047896 DOI:10.1097/PAS.0b013e31818afd6b]
23 Carr PR,Jansen L,Bienert S,Roth W,Herpel E,Kloor M,Bl?ker H,Chang-Claude J,Brenner H,Hoffmeister M.Associations of red and processed meat intake with major molecular pathological features of colorectal cancer.Eur J Epidemiol 2017;32:409-418[PMID:28646407 DOI:10.1007/s10654-017-0275-6]
24 Murff HJ,Shrubsole MJ,Cai Q,Smalley WE,Dai Q,Milne GL,Ness RM,Zheng W.Dietary intake of PUFAs and colorectal polyp risk.Am J Clin Nutr 2012;95:703-712[PMID:22277551 DOI:10.3945/ajcn.111.024000]
25 Kudryavtseva AV,Lipatova AV,Zaretsky AR,Moskalev AA,Fedorova MS,Rasskazova AS,Shibukhova GA,Snezhkina AV,Kaprin AD,Alekseev BY,Dmitriev AA,Krasnov GS.Important molecular genetic markers of colorectal cancer.Oncotarget 2016;7:53959-53983[PMID:27276710 DOI:10.18632/oncotarget.9796]
26 Raskov H,Pommergaard HC,Burcharth J,Rosenberg J.Colorectal carcinogenesis--update and perspectives.World J Gastroenterol2014;20:18151-18164[PMID:25561783 DOI:10.3748/wjg.v20.i48.18151]
27 Burghel GJ,Lin WY,Whitehouse H,Brock I,Hammond D,Bury J,Stephenson Y,George R,Cox A.Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer.PLo S One 2013;8:e83859[PMID:24367615 DOI:10.1371/journal.pone.0083859]
28 Iacopetta B,Grieu F,Amanuel B.Microsatellite instability in colorectal cancer.Asia Pac J Clin Oncol 2010;6:260-269[PMID:21114775 DOI:10.1111/j.1743-7563.2010.01335.x]
29 Slattery ML,Edwards SL,Samowitz W.Stage of colon cancer at diagnosis:implications for risk factor associations?Int J Epidemiol1998;27:382-387[PMID:9698124 DOI:10.1093/ije/27.3.382]
30 Freeman HJ.Early stage colon cancer.World J Gastroenterol 2013;19:8468-8473[PMID:24379564 DOI:10.3748/wjg.v19.i46.8468]
31 Hatano S,Ishida H,Ishibashi K,Kumamoto K,Haga N,Miura I.Identification of risk factors for recurrence in high-risk stage II colon cancer.Int Surg 2013;98:114-121[PMID:23701145 DOI:10.9738/CC131]
32 Robinson JR,Newcomb PA,Hardikar S,Cohen SA,Phipps AI.Stage IV colorectal cancer primary site and patterns of distant metastasis.Cancer Epidemiol 2017;48:92-95[PMID:28437692DOI:10.1016/j.canep.2017.04.003]
33 Johnson RL,Fleet JC.Animal models of colorectal cancer.Cancer Metastasis Rev 2013;32:39-61[PMID:23076650 DOI:10.1007/s10555-012-9404-6]
34 Rosenberg DW,Giardina C,Tanaka T.Mouse models for the study of colon carcinogenesis.Carcinogenesis 2009;30:183-196[PMID:19037092 DOI:10.1093/carcin/bgn267]
35 Edelmann L,Edelmann W.Loss of DNA mismatch repair function and cancer predisposition in the mouse:animal models for human hereditary nonpolyposis colorectal cancer.Am J Med Genet C Semin Med Genet 2004;129C:91-99[PMID:15264277 DOI:10.1002/ajmg.c.30021]
36 Moser AR,Pitot HC,Dove WF.A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.Science1990;247:322-324[PMID:2296722 DOI:10.1007/BF01186825]
37 Heyer J,Yang K,Lipkin M,Edelmann W,Kucherlapati R.Mouse models for colorectal cancer.Oncogene 1999;18:5325-5333[PMID:10498885 DOI:10.1038/sj.onc.1203036]
38 Reichling T,Goss KH,Carson DJ,Holdcraft RW,Ley-Ebert C,Witte D,Aronow BJ,Groden J.Transcriptional profiles of intestinal tumors in Apc(Min)mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.Cancer Res 2005;65:166-176[PMID:15665292]
39 Jin D,Liu T,Dong W,Zhang Y,Wang S,Xie R,Wang B,Cao H.Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apcmin/+mice.Oncotarget 2017;8:97787-97800[PMID:29228651 DOI:10.18632/oncotarget.22081]
40 Huang G,Khan I,Li X,Chen L,Leong W,Ho LT,Hsiao WLW.Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+mice.Sci Rep 2017;7:12552[PMID:28970547 DOI:10.1038/s41598-017-12644-5]
41 Bissahoyo A,Pearsall RS,Hanlon K,Amann V,Hicks D,Godfrey VL,Threadgill DW.Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice:effects of dose,route,and diet.Toxicol Sci 2005;88:340-345[PMID:16150884 DOI:10.1093/toxsci/kfi313]
42 Per?e M,Cerar A.Morphological and molecular alterations in 1,2dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats.J Biomed Biotechnol 2011;2011:473964[PMID:21253581DOI:10.1155/2011/473964]
43 Ashokkumar P,Sudhandiran G.Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway.Invest New Drugs 2011;29:273-284[PMID:20013030 DOI:10.1007/s10637-009-9359-9]
44 Miyaki M,Iijima T,Kimura J,Yasuno M,Mori T,Hayashi Y,Koike M,Shitara N,Iwama T,Kuroki T.Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.Cancer Res 1999;59:4506-4509[PMID:10493496]
45 Umesalma S,Sudhandiran G.Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappa B,i NOS,COX-2,TNF-alpha,and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.Basic Clin Pharmacol Toxicol 2010;107:650-655[PMID:20406206 DOI:10.1111/j.1742-7843.2010.00565.x]
46 Ordás I,Eckmann L,Talamini M,Baumgart DC,Sandborn WJ.Ulcerative colitis.Lancet 2012;380:1606-1619[PMID:22914296DOI:10.1016/S0140-6736(12)60150-0]
47 Kohno H,Suzuki R,Sugie S,Tanaka T.Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.Cancer Sci 2005;96:69-76[PMID:15723650 DOI:10.1111/j.1349-7006.2005.00020.x]
48 Jobst K.Teratogenous changes and tumors in rats following treatment with methylnitroso-urea(MNU).Neoplasma 1967;14:435-436[PMID:6063014]
49 Koestner AW,Ruecker FA,Koestner A.Morphology and pathogenesis of tumors of the thymus and stomach in Sprague-Dawley rats following intragastric administration of methyl nitrosourea(MNU).Int J Cancer 1977;20:418-426[PMID:903192DOI:10.1002/ijc.2910200314]
50 Maekawa A,Onodera H,Kanno J,Furuta K,Nagaoka T,Todate A,Matsushima Y,Oh-hara T,Kawazoe Y.Carcinogenicity and organ specificity of N-trimethylsilylmethyl-N-nitrosourea(TMS-MNU),N-neopentyl-N-nitrosourea(neo PNU),and N-methyl-N-nitrosourea(MNU)in rats.J Cancer Res Clin Oncol 1988;114:473-476[PMID:3182906 DOI:10.1007/BF00391494]
51 Almora-Pinedo Y,Arroyo-Acevedo J,Herrera-Calderon O,Chumpitaz-Cerrate V,Ha?ari-Quispe R,Tinco-Jayo A,Franco-Quino C,Figueroa-Salvador L.Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU)induced gastric cancer in rats.Clin Exp Gastroenterol 2017;10:327-332[PMID:29270029 DOI:10.2147/CEG.S142515]
52 Pollard M,Luckert PH.Autochthonous prostate adenocarcinomas in Lobund-Wistar rats:a model system.Prostate 1987;11:219-227[PMID:3684782 DOI:10.1002/pros.2990110303]
53 Narisawa T,Wong CQ,Maronpot RR,Weisburger JH.Large bowel carcinogenesis in mice and rats by several intrarectal doses of methylnitrosourea and negative effect of nitrite plus methylurea.Cancer Res 1976;36:505-510[PMID:1260748]
54 Magalh?es B,Peleteiro B,Lunet N.Dietary patterns and colorectal cancer:systematic review and meta-analysis.Eur JCancer Prev 2012;21:15-23[PMID:21946864 DOI:10.1097/CEJ.0b013e3283472241]
55 Newmark HL,Yang K,Kurihara N,Fan K,Augenlicht LH,Lipkin M.Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice:a preclinical model for human sporadic colon cancer.Carcinogenesis 2009;30:88-92[PMID:19017685 DOI:10.1093/carcin/bgn229]
56 Newmark HL,Lipkin M,Maheshwari N.Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet.J Natl Cancer Inst 1990;82:491-496[PMID:2313721 DOI:10.1093/jnci/82.6.491]
57 Risio M,Lipkin M,Newmark H,Yang K,Rossini FP,Steele VE,Boone CW,Kelloff GJ.Apoptosis,cell replication,and Western-style diet-induced tumorigenesis in mouse colon.Cancer Res 1996;56:4910-4916[PMID:8895743]
58 Wang D,Peregrina K,Dhima E,Lin EY,Mariadason JM,Augenlicht LH.Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer.Proc Natl Acad Sci USA 2011;108:10272-10277[PMID:21652773 DOI:10.1073/pnas.1017668108]
59 Muto T,Bussey HJ,Morson BC.The evolution of cancer of the colon and rectum.Cancer 1975;36:2251-2270[PMID:1203876DOI:10.1002/cncr.2820360944]
60 Subramaniam R,Mizoguchi A,Mizoguchi E.Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.Cancer Res Front 2016;2:1-21[PMID:27110580 DOI:10.17980/2016.1]
61 Xu J,Lamouille S,Derynck R.TGF-beta-induced epithelial to mesenchymal transition.Cell Res 2009;19:156-172[PMID:19153598 DOI:10.1038/cr.2009.5]
62 Varga J,Greten FR.Cell plasticity in epithelial homeostasis and tumorigenesis.Nat Cell Biol 2017;19:1133-1141[PMID:28945230DOI:10.1038/ncb3611]
63 Thiery JP,Acloque H,Huang RY,Nieto MA.Epithelial-mes-enchymal transitions in development and disease.Cell 2009;139:871-890[PMID:19945376 DOI:10.1016/j.cell.2009.11.007]
64?kovierováH,Okaj?ekováT,Strnádel J,VidomanováE,Hala?ováE.Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis(Review).Int J Mol Med 2018;41:1187-1200[PMID:29286071 DOI:10.3892/ijmm.2017.3320]
65 Ansieau S,Bastid J,Doreau A,Morel AP,Bouchet BP,Thomas C,Fauvet F,Puisieux I,Doglioni C,Piccinin S,Maestro R,Voeltzel T,Selmi A,Valsesia-Wittmann S,Caron de Fromentel C,Puisieux A.Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.Cancer Cell 2008;14:79-89[PMID:18598946 DOI:10.1016/j.ccr.2008.06.005]
66 Lazarova DL,Bordonaro M.Vimentin,colon cancer progression and resistance to butyrate and other HDACis.J Cell Mol Med 2016;20:989-993[PMID:27072512 DOI:10.1111/jcmm.12850]
67 Meacham CE,Morrison SJ.Tumour heterogeneity and cancer cell plasticity.Nature 2013;501:328-337[PMID:24048065 DOI:10.1038/nature12624]
68 Yao D,Dai C,Peng S.Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.Mol Cancer Res 2011;9:1608-1620[PMID:21840933 DOI:10.1158/1541-7786.MCR-10-0568]
69 Christou N,Perraud A,Blondy S,Jauberteau MO,Battu S,Mathonnet M.E-cadherin:A potential biomarker of colorectal cancer prognosis.Oncol Lett 2017;13:4571-4576[PMID:28588719 DOI:10.3892/ol.2017.6063]
70 Choi BJ,Park SA,Lee SY,Cha YN,Surh YJ.Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail:Apotential role of Sox9.Sci Rep 2017;7:15918[PMID:29162839DOI:10.1038/s41598-017-15139-5]
71 Loboda A,Nebozhyn MV,Watters JW,Buser CA,Shaw PM,Huang PS,Van't Veer L,Tollenaar RA,Jackson DB,Agrawal D,Dai H,Yeatman TJ.EMT is the dominant program in human colon cancer.BMC Med Genomics 2011;4:9[PMID:21251323 DOI:10.1186/1755-8794-4-9]
72 Clarke PG,Clarke S.Nineteenth century research on naturally occurring cell death and related phenomena.Anat Embryol(Berl)1996;193:81-99[PMID:8742050 DOI:10.1007/BF00214700]
73 Galluzzi L,Vitale I,Aaronson SA,Abrams JM,Adam D,Agostinis P,Alnemri ES,Altucci L,Amelio I,Andrews DW,Annicchiarico-Petruzzelli M,Antonov AV,Arama E,Baehrecke EH,Barlev NA,Bazan NG,Bernassola F,Bertrand MJM,Bianchi K,Blagosklonny MV,Blomgren K,Borner C,Boya P,Brenner C,Campanella M,Candi E,Carmona-Gutierrez D,Cecconi F,Chan FK,Chandel NS,Cheng EH,Chipuk JE,Cidlowski JA,Ciechanover A,Cohen GM,Conrad M,Cubillos-Ruiz JR,Czabotar PE,D'Angiolella V,Dawson TM,Dawson VL,De Laurenzi V,De Maria R,Debatin KM,De Berardinis RJ,Deshmukh M,Di Daniele N,Di Virgilio F,Dixit VM,Dixon SJ,Duckett CS,Dynlacht BD,El-Deiry WS,Elrod JW,Fimia GM,Fulda S,García-Sáez AJ,Garg AD,Garrido C,Gavathiotis E,Golstein P,Gottlieb E,Green DR,Greene LA,Gronemeyer H,Gross A,Hajnoczky G,Hardwick JM,Harris IS,Hengartner MO,Hetz C,Ichijo H,J??ttel?M,Joseph B,Jost PJ,Juin PP,Kaiser WJ,Karin M,Kaufmann T,Kepp O,Kimchi A,Kitsis RN,Klionsky DJ,Knight RA,Kumar S,Lee SW,Lemasters JJ,Levine B,Linkermann A,Lipton SA,Lockshin RA,López-Otín C,Lowe SW,Luedde T,Lugli E,Mac Farlane M,Madeo F,Malewicz M,Malorni W,Manic G,Marine JC,Martin SJ,Martinou JC,Medema JP,Mehlen P,Meier P,Melino S,Miao EA,Molkentin JD,Moll UM,Mu?oz-Pinedo C,Nagata S,Nu?ez G,Oberst A,Oren M,Overholtzer M,Pagano M,Panaretakis T,Pasparakis M,Penninger JM,Pereira DM,Pervaiz S,Peter ME,Piacentini M,Pinton P,Prehn JHM,Puthalakath H,Rabinovich GA,Rehm M,Rizzuto R,Rodrigues CMP,Rubinsztein DC,Rudel T,Ryan KM,Sayan E,Scorrano L,Shao F,Shi Y,Silke J,Simon HU,Sistigu A,Stockwell BR,Strasser A,Szabadkai G,Tait SWG,Tang D,Tavernarakis N,Thorburn A,Tsujimoto Y,Turk B,Vanden Berghe T,Vandenabeele P,Vander Heiden MG,Villunger A,Virgin HW,Vousden KH,Vucic D,Wagner EF,Walczak H,Wallach D,Wang Y,Wells JA,Wood W,Yuan J,Zakeri Z,Zhivotovsky B,Zitvogel L,Melino G,Kroemer G.Molecular mechanisms of cell death:recommendations of the Nomenclature Committee on Cell Death2018.Cell Death Differ 2018;25:486-541[PMID:29362479 DOI:10.1038/s41418-017-0012-4]
74 Fulda S.Regulation of cell death in cancer-possible implications for immunotherapy.Front Oncol 2013;3:29[PMID:23441073 DOI:10.3389/fonc.2013.00029]
75 Letai A.Cell Death and Cancer Therapy:Don't Forget to Kill the Cancer Cell!Clin Cancer Res 2015;21:5015-5020[PMID:26567360 DOI:10.1158/1078-0432.CCR-15-1204]
76 Ricci MS,Zong WX.Chemotherapeutic approaches for targeting cell death pathways.Oncologist 2006;11:342-357[PMID:16614230 DOI:10.1634/theoncologist.11-4-342]
77 Nievelstein RA,van der Werff JF,Verbeek FJ,Valk J,Vermeij-Keers C.Normal and abnormal embryonic development of the anorectum in human embryos.Teratology 1998;57:70-78[PMID:9562679 DOI:10.1002/(SICI)1096-9926(199802)57:2<70::AID-TERA5>3.0.CO;2-A]
78 Zhang T,Zhang HL,Wang da J,Tang XB,Jia HM,Bai YZ,Yuan ZW,Wang WL.Normal development of hindgut and anorectum in human embryo.Int J Colorectal Dis 2011;26:109-116[PMID:20686776 DOI:10.1007/s00384-010-1034-2]
79 Nakata M,Takada Y,Hishiki T,Saito T,Terui K,Sato Y,Koseki H,Yoshida H.Induction of Wnt5a-expressing mesenchymal cells adjacent to the cloacal plate is an essential process for its proximodistal elongation and subsequent anorectal development.Pediatr Res 2009;66:149-154[PMID:19390486 DOI:10.1203/PDR.0b013e3181aa304a]
80 Zhang T,Tang XB,Wang LL,Bai YZ,Qiu GR,Yuan ZW,Wang WL.Mutations and down-regulation of CDX1 in children with anorectal malformations.Int J Med Sci 2013;10:191-197[PMID:23329892 DOI:10.7150/ijms.4929]
81 Qu X,Zou Z,Sun Q,Luby-Phelps K,Cheng P,Hogan RN,Gilpin C,Levine B.Autophagy gene-dependent clearance of apoptotic cells during embryonic development.Cell 2007;128:931-946[PMID:17350577 DOI:10.1016/j.cell.2006.12.044]
82 Yuan J,Kroemer G.Alternative cell death mechanisms in development and beyond.Genes Dev 2010;24:2592-2602[PMID:21123646 DOI:10.1101/gad.1984410]
83 Zhou W,Yuan J.Necroptosis in health and diseases.Semin Cell Dev Biol 2014;35:14-23[PMID:25087983 DOI:10.1016/j.semcdb.2014.07.013]
84 Xie Y,Hou W,Song X,Yu Y,Huang J,Sun X,Kang R,Tang D.Ferroptosis:process and function.Cell Death Differ 2016;23:369-379[PMID:26794443 DOI:10.1038/cdd.2015.158]
85 Vande Walle L,Lamkanfi M.Pyroptosis.Curr Biol 2016;26:R568-R572[PMID:27404251 DOI:10.1016/j.cub.2016.02.019]
86 Fatokun AA,Dawson VL,Dawson TM.Parthanatos:mitochondrial-linked mechanisms and therapeutic opportunities.Br J Pharmacol2014;171:2000-2016[PMID:24684389 DOI:10.1111/bph.12416]
87 Kroemer G,Perfettini JL.Entosis,a key player in cancer cell competition.Cell Res 2014;24:1280-1281[PMID:25342563 DOI:10.1038/cr.2014.133]
88 Mesa MA,Vasquez G.NETosis.Autoimmune Dis 2013;2013:651497[PMID:23476749 DOI:10.1155/2013/651497]
89 Kim KH,Lee MS.Autophagy--a key player in cellular and body metabolism.Nat Rev Endocrinol 2014;10:322-337[PMID:24663220 DOI:10.1038/nrendo.2014.35]
90 Galluzzi L,Bravo-San Pedro JM,Kepp O,Kroemer G.Regulated cell death and adaptive stress responses.Cell Mol Life Sci 2016;73:2405-2410[PMID:27048813 DOI:10.1007/s00018-016-2209-y]
91 Wong DJ,Liu H,Ridky TW,Cassarino D,Segal E,Chang HY.Module map of stem cell genes guides creation of epithelial cancer stem cells.Cell Stem Cell 2008;2:333-344[PMID:18397753 DOI:10.1016/j.stem.2008.02.009]
92 Fearon ER.Molecular genetics of colorectal cancer.Annu Rev Pathol 2011;6:479-507[PMID:21090969 DOI:10.1146/annurev-pathol-011110-130235]
93 Marshman E,Ottewell PD,Potten CS,Watson AJ.Caspase acti-vation during spontaneous and radiation-induced apoptosis in the murine intestine.J Pathol 2001;195:285-292[PMID:11673824DOI:10.1002/path.967]
94 Manne U,Shanmugam C,Katkoori VR,Bumpers HL,Grizzle WE.Development and progression of colorectal neoplasia.Cancer Biomark 2010;9:235-265[PMID:22112479 DOI:10.3233/CBM-2011-0160]
95 Li XL,Zhou J,Chen ZR,Chng WJ.P53 mutations in colorectal cancer-molecular pathogenesis and pharmacological reactivation.World J Gastroenterol 2015;21:84-93[PMID:25574081 DOI:10.3748/wjg.v21.i1.84]
96 Kumar M,Kaur V,Kumar S,Kaur S.Phytoconstituents as apoptosis inducing agents:strategy to combat cancer.Cytotechnology 2016;68:531-563[PMID:26239338 DOI:10.1007/s10616-015-9897-2]
97 Pandurangan AK,Dharmalingam P,Sadagopan SK,Ramar M,Munusamy A,Ganapasam S.Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/GSK-3βsignaling.J Environ Pathol Toxicol Oncol 2013;32:131-139[PMID:24099426 DOI:10.1615/JEnviron Pathol Toxicol Oncol.2013007522]
98 Gerola S,Nittka S,K?hler G,Tao S,Brenner H,Binelli G,Eils R,Brors B,Neumaier M.Genetic variants in apoptosis-related genes associated with colorectal hyperplasia.Genes Chromosomes Cancer2014;53:769-778[PMID:24861865 DOI:10.1002/gcc.22185]
99 Sinicrope FA,Hart J,Hsu HA,Lemoine M,Michelassi F,Stephens LC.Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.Clin Cancer Res 1999;5:1793-1804[PMID:10430084]
100 Danielsen SA,Eide PW,Nesbakken A,Guren T,Leithe E,Lothe RA.Portrait of the PI3K/AKT pathway in colorectal cancer.Biochim Biophys Acta 2015;1855:104-121[PMID:25450577 DOI:10.1016/j.bbcan.2014.09.008]
101 Kenific CM,Thorburn A,Debnath J.Autophagy and metastasis:another double-edged sword.Curr Opin Cell Biol 2010;22:241-245[PMID:19945838 DOI:10.1016/j.ceb.2009.10.008]
102 Chen Z,Li Y,Zhang C,Yi H,Wu C,Wang J,Liu Y,Tan J,Wen J.Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer.Dig Dis Sci 2013;58:2887-2894[PMID:23812859 DOI:10.1007/s10620-013-2732-8]
103 Moriwaki K,Bertin J,Gough PJ,Orlowski GM,Chan FK.Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Cell Death Dis2015;6:e1636[PMID:25675296 DOI:10.1038/cddis.2015.16]
104 Xie X,Zhao Y,Ma CY,Xu XM,Zhang YQ,Wang CG,Jin J,Shen X,Gao JL,Li N,Sun ZJ,Dong DL.Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROSincrease/MAPKs activation pathway.Br J Pharmacol 2015;172:3929-3943[PMID:25953698 DOI:10.1111/bph.13184]
105 Oliver Metzig M,Fuchs D,Tagscherer KE,Gr?ne HJ,Schirmacher P,Roth W.Inhibition of caspases primes colon cancer cells for5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.Oncogene 2016;35:3399-3409[PMID:26522725 DOI:10.1038/onc.2015.398]
106 Katz LH,Li Y,Chen JS,Mu?oz NM,Majumdar A,Chen J,Mishra L.Targeting TGF-βsignaling in cancer.Expert Opin Ther Targets2013;17:743-760[PMID:23651053 DOI:10.1517/14728222.2013.782287]
107 Goel S,Huang J,Klampfer L.K-Ras,intestinal homeostasis and colon cancer.Curr Clin Pharmacol 2015;10:73-81[PMID:24219000 DOI:10.2174/1574884708666131111204440]
108 Giles RH,van Es JH,Clevers H.Caught up in a Wnt storm:Wnt signaling in cancer.Biochim Biophys Acta 2003;1653:1-24[PMID:12781368 DOI:10.1016/S0304-419X(03)00005-2]
109 Segditsas S,Tomlinson I.Colorectal cancer and genetic alterations in the Wnt pathway.Oncogene 2006;25:7531-7537[PMID:17143297 DOI:10.1038/sj.onc.1210059]
110 Rosin-Arbesfeld R,Townsley F,Bienz M.The APC tumour suppressor has a nuclear export function.Nature 2000;406:1009-1012[PMID:10984057 DOI:10.1038/35023016]
111 Fevr T,Robine S,Louvard D,Huelsken J.Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.Mol Cell Biol 2007;27:7551-7559[PMID:17785439DOI:10.1128/MCB.01034-07]
112 Hanahan D,Weinberg RA.Hallmarks of cancer:the next genera-tion.Cell 2011;144:646-674[PMID:21376230 DOI:10.1016/j.cell.2011.02.013]
113 Fortin J,Mak TW.Targeting PI3K Signaling in Cancer:ACautionary Tale of Two AKTs.Cancer Cell 2016;29:429-431[PMID:27070694 DOI:10.1016/j.ccell.2016.03.020]
114 Colakoglu T,Yildirim S,Kayaselcuk F,Nursal TZ,Ezer A,Noyan T,Karakayali H,Haberal M.Clinicopathological significance of PTENloss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms:is PTEN loss predictor of local recurrence?Am J Surg 2008;195:719-725[PMID:18440486 DOI:10.1016/j.amjsurg.2007.05.061]
115 Lin MC,Wang FY,Kuo YH,Tang FY.Cancer chemopreventive effects of lycopene:suppression of MMP-7 expression and cell invasion in human colon cancer cells.J Agric Food Chem 2011;59:11304-11318[PMID:21923160 DOI:10.1021/jf202433f]
116 Din FV,Valanciute A,Houde VP,Zibrova D,Green KA,Sakamoto K,Alessi DR,Dunlop MG.Aspirin inhibits m TOR signaling,activates AMP-activated protein kinase,and induces autophagy in colorectal cancer cells.Gastroenterology 2012;142:1504-1515.e3[PMID:22406476 DOI:10.1053/j.gastro.2012.02.050]
117 MassaguéJ.TGF-beta signal transduction.Annu Rev Biochem1998;67:753-791[PMID:9759503 DOI:10.1146/annurev.biochem.67.1.753]
118 Kaklamani VG,Pasche B.Role of TGF-beta in cancer and the potential for therapy and prevention.Expert Rev Anticancer Ther2004;4:649-661[PMID:15270668 DOI:10.1586/14737140.4.4.649]
119 Xu Y,Pasche B.TGF-beta signaling alterations and susceptibility to colorectal cancer.Hum Mol Genet 2007;16 Spec No 1:R14-R20[PMID:17613544 DOI:10.1093/hmg/ddl486]
120 Leask A,Abraham DJ.TGF-beta signaling and the fibrotic response.FASEB J 2004;18:816-827[PMID:15117886 DOI:10.1096/fj.03-1273rev]
121 Javelaud D,Mauviel A.Mammalian transforming growth factor-betas:Smad signaling and physio-pathological roles.Int J Biochem Cell Biol 2004;36:1161-1165[PMID:15109563 DOI:10.1016/S1357-2725(03)00255-3]
122 Clark DA,Coker R.Transforming growth factor-beta(TGF-beta).Int J Biochem Cell Biol 1998;30:293-298[PMID:9611771 DOI:10.1016/S1357-2725(97)00128-3]
123 Bellam N,Pasche B.Tgf-beta signaling alterations and colon cancer.Cancer Treat Res 2010;155:85-103[PMID:20517689 DOI:10.1007/978-1-4419-6033-7_5]
124 Letterio JJ,Roberts AB.Regulation of immune responses by TGF-beta.Annu Rev Immunol 1998;16:137-161[PMID:9597127 DOI:10.1146/annurev.immunol.16.1.137]
125 Geng L,Chaudhuri A,Talmon G,Wisecarver JL,Wang J.TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.PLo S One 2013;8:e59918[PMID:23536895 DOI:10.1371/journal.pone.0059918]
126 Gatza CE,Holtzhausen A,Kirkbride KC,Morton A,Gatza ML,Datto MB,Blobe GC.Type III TGF-βreceptor enhances colon cancer cell migration and anchorage-independent growth.Neoplasia2011;13:758-770[PMID:21847367 DOI:10.1593/neo.11528]
127 Oshima H,Nakayama M,Han TS,Naoi K,Ju X,Maeda Y,Robine S,Tsuchiya K,Sato T,Sato H,Taketo MM,Oshima M.Suppressing TGFβsignaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.Cancer Res 2015;75:766-776[PMID:25687406 DOI:10.1158/0008-5472.CAN-14-2036]
128 Ruzzo A,Graziano F,Canestrari E,Magnani M.Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.Curr Cancer Drug Targets 2010;10:68-79[PMID:20088793 DOI:10.2174/156800910790980205]
129 Mendelsohn J.The epidermal growth factor receptor as a target for cancer therapy.Endocr Relat Cancer 2001;8:3-9[PMID:11350723DOI:10.1677/erc.0.0080003]
130 Rotter V,Prokocimer M.p53 and human malignancies.Adv Cancer Res 1991;57:257-272[PMID:1950705 DOI:10.1016/S0065-230X(08)61001-5]
131 Hsieh JS,Lin SR,Chang MY,Chen FM,Lu CY,Huang TJ,Huang YS,Huang CJ,Wang JY.APC,K-ras,and p53 gene mutations in colorectal cancer patients:correlation to clinicopathologic features and postoperative surveillance.Am Surg 2005;71:336-343[PMID:15943410]
132 Artavanis-Tsakonas S,Rand MD,Lake RJ.Notch signaling:cell fate control and signal integration in development.Science 1999;284:770-776[PMID:10221902 DOI:10.1126/science.284.5415.770]
133 Bray SJ.Notch signalling in context.Nat Rev Mol Cell Biol 2016;17:722-735[PMID:27507209 DOI:10.1038/nrm.2016.94]
134 Schmidt EM,Lamprecht S,Blaj C,Schaaf C,Krebs S,Blum H,Hermeking H,Jung A,Kirchner T,Horst D.Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer.J Exp Med 2018;215:1693-1708[PMID:29769248DOI:10.1084/jem.20171455]
135 Mirone G,Perna S,Shukla A,Marfe G.Involvement of Notch-1in Resistance to Regorafenib in Colon Cancer Cells.J Cell Physiol2016;231:1097-1105[PMID:26419617 DOI:10.1002/jcp.25206]
136 Kranenburg O.Prometastatic NOTCH Signaling in Colon Cancer.Cancer Discov 2015;5:115-117[PMID:25656897 DOI:10.1158/2159-8290.CD-14-1456]
137 Rajendran P,Dashwood WM,Li L,Kang Y,Kim E,Johnson G,Fischer KA,L?hr CV,Williams DE,Ho E,Yamamoto M,Lieberman DA,Dashwood RH.Nrf2 status affects tumor growth,HDAC3 gene promoter associations,and the response to sulforaphane in the colon.Clin Epigenetics 2015;7:102[PMID:26388957 DOI:10.1186/s13148-015-0132-y]
138 Copple IM.The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?Adv Pharmacol 2012;63:43-79[PMID:22776639 DOI:10.1016/B978-0-12-398339-8.00002-1]
139 Manigandan K,Manimaran D,Jayaraj RL,Elangovan N,Dhivya V,Kaphle A.Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.Biochimie 2015;119:103-112[PMID:26482805DOI:10.1016/j.biochi.2015.10.014]
140 Niture SK,Khatri R,Jaiswal AK.Regulation of Nrf2-an update.Free Radic Biol Med 2014;66:36-44[PMID:23434765 DOI:10.1016/j.freeradbiomed.2013.02.008]
141 Jaramillo MC,Zhang DD.The emerging role of the Nrf2-Keap1signaling pathway in cancer.Genes Dev 2013;27:2179-2191[PMID:24142871 DOI:10.1101/gad.225680.113]
142 Yang Y,Cai X,Yang J,Sun X,Hu C,Yan Z,Xu X,Lu W,Wang X,Cao P.Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation.Mol Cancer 2014;13:48[PMID:24602443 DOI:10.1186/1476-4598-13-48]
143 Yao J,Zhao L,Zhao Q,Zhao Y,Sun Y,Zhang Y,Miao H,You QD,Hu R,Guo QL.NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis.Cell Death Dis 2014;5:e1283[PMID:24901054DOI:10.1038/cddis.2014.221]
144 Wondrak GT,Villeneuve NF,Lamore SD,Bause AS,Jiang T,Zhang DD.The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells.Molecules 2010;15:3338-3355[PMID:20657484 DOI:10.3390/molecules15053338]
145 Irvine KD,Harvey KF.Control of organ growth by patterning and hippo signaling in Drosophila.Cold Spring Harb Perspect Biol2015;7:pii:a019224[PMID:26032720 DOI:10.1101/cshperspect.a019224]
146 Kosik KS,Kowall NW,Mc Kee A.Along the way to a neurofibrillary tangle:a look at the structure of tau.Ann Med 1989;21:109-112[PMID:2504256 DOI:10.3109/07853898909149195]
147 Santucci M,Vignudelli T,Ferrari S,Mor M,Scalvini L,Bolognesi ML,Uliassi E,Costi MP.The Hippo Pathway and YAP/TAZ-TEADProtein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.J Med Chem 2015;58:4857-4873[PMID:25719868 DOI:10.1021/jm501615v]
148 Nagashima S,Bao Y,Hata Y.The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.Curr Drug Targets2017;18:447-454[PMID:26758663 DOI:10.2174/1389450117666160112115641]
149 Guo L,Teng L.YAP/TAZ for cancer therapy:opportunities and challenges(review).Int J Oncol 2015;46:1444-1452[PMID:25652178 DOI:10.3892/ijo.2015.2877]
150 Hansen CG,Moroishi T,Guan KL.YAP and TAZ:a nexus for Hippo signaling and beyond.Trends Cell Biol 2015;25:499-513[PMID:26045258 DOI:10.1016/j.tcb.2015.05.002]
151 Liang K,Zhou G,Zhang Q,Li J,Zhang C.Expression of hippo pathway in colorectal cancer.Saudi J Gastroenterol 2014;20:188-194[PMID:24976283 DOI:10.4103/1319-3767.133025]
152 Cho SY,Gwak JW,Shin YC,Moon D,Ahn J,Sol HW,Kim S,Kim G,Shin HM,Lee KH,Kim JY,Kim JS.Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.Oncol Lett 2018;15:4926-4936[PMID:29541248DOI:10.3892/ol.2018.7911]
153 Konsavage WM Jr,Kyler SL,Rennoll SA,Jin G,Yochum GS.Wnt/β-catenin signaling regulates Yes-associated protein(YAP)gene expression in colorectal carcinoma cells.J Biol Chem 2012;287:11730-11739[PMID:22337891 DOI:10.1074/jbc.M111.327767]
154 Kim M,Jho EH.Cross-talk between Wnt/β-catenin and Hippo signaling pathways:a brief review.BMB Rep 2014;47:540-545[PMID:25154721 DOI:10.5483/BMBRep.2014.47.10.177]
155 Tanaka T.Colorectal carcinogenesis:Review of human and experimental animal studies.J Carcinog 2009;8:5[PMID:19332896 DOI:10.4103/1477-3163.49014]
156 Rupaimoole R,Slack FJ.Micro RNA therapeutics:towards a new era for the management of cancer and other diseases.Nat Rev Drug Discov 2017;16:203-222[PMID:28209991 DOI:10.1038/nrd.2016.246]
157 Jansson MD,Lund AH.Micro RNA and cancer.Mol Oncol 2012;6:590-610[PMID:23102669 DOI:10.1016/j.molonc.2012.09.006]
158 Masuda T,Hayashi N,Kuroda Y,Ito S,Eguchi H,Mimori K.Micro RNAs as Biomarkers in Colorectal Cancer.Cancers(Basel)2017;9:pii:E124[PMID:28902152 DOI:10.3390/cancers9090124]
159 DegagnéE,Pandurangan A,Bandhuvula P,Kumar A,Eltanawy A,Zhang M,Yoshinaga Y,Nefedov M,de Jong PJ,Fong LG,Young SG,Bittman R,Ahmedi Y,Saba JD.Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated micro RNAs.J Clin Invest 2014;124:5368-5384[PMID:25347472 DOI:10.1172/JCI74188]
160 Cao L,Liu Y,Wang D,Huang L,Li F,Liu J,Zhang C,Shen Z,Gao Q,Yuan W,Zhang Y.Mi R-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclin D1 signaling.J Exp Clin Cancer Res 2018;37:83[PMID:29661228 DOI:10.1186/s13046-018-0757-8]
161 Zhang W,Sun Z,Su L,Wang F,Jiang Y,Yu D,Zhang F,Sun Z,Liang W.mi RNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.Eur JPharmacol 2018;825:75-84[PMID:29454608 DOI:10.1016/j.ejphar.2018.02.019]